Aducanumab FDA Approval for Alzheimer's Disease: The Importance of G…

Anton Porsteinsson

Differentiating Early Signs of Alzheimer Disease From Normal Signs o…

ACHL

J. Galvin

Cognitive Disorders

ZINCARE

M. Mataa

Gut Microbiome and the Brain

BRAIN PONDERINGS podcast with Mark Mattson

J. Cryan

Approach to Cognitive Impairment in Adults

ZINCARE

M. Mataa

AAIC 2024 Insights: Potential of Targeting the Alpha-1 Adrenergic Re…

AAIC 2024 Insights Hub

S. G. Pattanashetty

AAIC 2024 Insights: Reducing the Effects of Aging on Cognition With …

AAIC 2024 Insights Hub

C. Camargo

Early Diagnosis of Alzheimer’s Disease

Sharon Cohen

Updates in Dementia

2023 Conference Coverage

P. Tipton

AAIC 2024 Insights: Developing an AI Algorithm to Detect Predictors …

AAIC 2024 Insights Hub

J. Butler

AAIC 2024 Insights: qEEG as Biomarker for Alzheimer's Disease - Inve…

AAIC 2024 Insights Hub

C. Simfukwe

Alzheimer's: Clinical Pearls

Lawrence Robbins

Conference Highlights: When the Patient Isn't Getting Better - A Psy…

2024 Conference Highlights

E. Plakun

The Illusion of Progress: Lecanemab in Alzheimer's Disease

Alberto Espay

AAIC 2024 Insights: Plasma Aβ42/Aβ40 and Phospho-Tau217 Concentratio…

AAIC 2024 Insights Hub

R. Rissman

A New Era for Brain Health in Primary Care: New Drugs and Diagnostics

University of Kansas Medical Center

J. M. Burns

An Update on Alzheimer's Disease: New Strategies Across the Disease …

Miller Medical Communications

P. Tariot

AAIC 2024 Insights: Subclinical Atherosclerosis and Brain Health in …

AAIC 2024 Insights Hub

C. Tristão Pereira

Gut Microbiome Signatures of Brain Aging and Alzheimer's Disease

Texas Alzheimer’s Research and Care Consortium

C. L. Satizabal

AAIC 2024 Insights: Altered Cerebral Blood Flow as a Screening Test …

AAIC 2024 Insights Hub

A. Ricaurte-Fajardo